A detailed history of High Tower Advisors, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 32,690 shares of EYPT stock, worth $394,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,690
Previous 30,690 6.52%
Holding current value
$394,895
Previous $634,000 55.21%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.16 - $22.89 $16,320 - $45,780
2,000 Added 6.52%
32,690 $284,000
Q1 2024

May 06, 2024

BUY
$19.93 - $29.71 $13,612 - $20,291
683 Added 2.28%
30,690 $634,000
Q4 2023

Feb 12, 2024

SELL
$5.71 - $24.13 $1.27 Million - $5.38 Million
-222,965 Reduced 88.14%
30,007 $693,000
Q3 2023

Nov 08, 2023

SELL
$7.99 - $15.36 $366,197 - $703,979
-45,832 Reduced 15.34%
252,972 $2.02 Million
Q4 2021

Feb 10, 2022

SELL
$10.18 - $18.4 $2.34 Million - $4.23 Million
-229,624 Reduced 43.45%
298,804 $3.66 Million
Q2 2021

Aug 06, 2021

SELL
$8.69 - $11.08 $347 - $443
-40 Reduced 0.01%
528,428 $4.75 Million
Q4 2020

Feb 10, 2021

BUY
$3.7 - $6.58 $1.96 Million - $3.48 Million
528,468 New
528,468 $3.48 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $412M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.